blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2504331

EP2504331 - COMPOUND, CERTAIN NOVEL FORMS THEREOF, PHARMACEUTICAL COMPOSITIONS THEREOF AND METHODS FOR PREPARATION AND USE [Right-click to bookmark this link]
StatusOpposition rejected
Status updated on  10.02.2017
Database last updated on 02.09.2024
Most recent event   Tooltip12.10.2018Lapse of the patent in a contracting state
New state(s): AL
published on 14.11.2018  [2018/46]
Applicant(s)For all designated states
Hutchison Medipharma Limited
720 Cai Lun Road Building 4
Pudong, Shanghai 201203 / CN
[2012/40]
Inventor(s)01 / SU, Wei-Guo
720 Cai Lun Road Building 4
Pudong Shanghai 201203 / CN
02 / ZHANG, Weihan
720 Cai Lun Road Building 4
Pudong Shanghai 201203 / CN
03 / JIA, Hong
720 Cai Lun Road Building 4
Pudong Shanghai 201203 / CN
04 / CUI, Yumin
720 Cai Lun Road Building 4
Pudong Shanghai 201203 / CN
05 / REN, Yongxin
720 Cai Lun Road Building 4
Pudong Shanghai 201203 / CN
06 / SAI, Yang
720 Cai Lun Road Building 4
Pudong Shanghai 201203 / CN
07 / WU, Zhenping
720 Cai Lun Road Building 4
Pudong Shanghai 201203 / CN
08 / LI, Wenji
720 Cai Lun Road Building 4
Pudong Shanghai 201203 / CN
09 / SHAO, Jiangyong
720 Cai Lun Road Building 4
Pudong Shanghai 201203 / CN
10 / TIAN, Zhenping
720 Cai Lun Road
Building 4
Pudong Shanghai 201203 / CN
 [2012/40]
Representative(s)Carpmaels & Ransford LLP
One Southampton Row
London WC1B 5HA / GB
[N/P]
Former [2014/46]Howard, Paul Nicholas
Carpmaels & Ransford LLP
One Southampton Row
London WC1B 5HA / GB
Former [2012/40]Howard, Paul Nicholas
Carpmaels & Ransford One Southampton Row London
WC1B 5HA / GB
Application number, filing date10831161.423.11.2010
WO2010CN78997
Priority number, dateCN20091019925923.11.2009         Original published format: CN200910199259
[2012/40]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2011060746
Date:26.05.2011
Language:EN
[2011/21]
Type: A1 Application with search report 
No.:EP2504331
Date:03.10.2012
Language:EN
The application published by WIPO in one of the EPO official languages on 26.05.2011 takes the place of the publication of the European patent application.
[2012/40]
Type: B1 Patent specification 
No.:EP2504331
Date:12.11.2014
Language:EN
[2014/46]
Search report(s)International search report - published on:CN26.05.2011
(Supplementary) European search report - dispatched on:EP15.03.2013
ClassificationIPC:C07D403/12, A61K31/506, A61P9/00, A61P35/00
[2012/40]
CPC:
C07D403/12 (EP,KR,US); A61K31/506 (KR,US); A61P27/02 (EP);
A61P29/00 (EP); A61P35/00 (EP); A61P35/02 (EP);
A61P43/00 (EP); A61P9/00 (EP) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2012/40]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:VERBINDUNG, BESTIMMTE NEUE FORMEN DAVON, PHARMAZEUTISCHE ZUSAMMENSETZUNGEN DARAUS SOWIE VERFAHREN ZU IHRER HERSTELLUNG UND VERWENDUNG[2012/40]
English:COMPOUND, CERTAIN NOVEL FORMS THEREOF, PHARMACEUTICAL COMPOSITIONS THEREOF AND METHODS FOR PREPARATION AND USE[2012/40]
French:COMPOSÉ, CERTAINES NOUVELLES FORMES DE CELUI-CI, COMPOSITIONS PHARMACEUTIQUES DE CELUI-CI ET PROCÉDÉS DE PRÉPARATION ET D'UTILISATION[2012/40]
Entry into regional phase15.06.2012National basic fee paid 
15.06.2012Search fee paid 
15.06.2012Designation fee(s) paid 
15.06.2012Examination fee paid 
Examination procedure15.06.2012Examination requested  [2012/40]
14.10.2013Amendment by applicant (claims and/or description)
22.05.2014Communication of intention to grant the patent
01.10.2014Fee for grant paid
01.10.2014Fee for publishing/printing paid
01.10.2014Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  22.05.2014
Opposition(s)Opponent(s)01  12.08.2015    ADMISSIBLE
Generics [UK] Limited (trading as Mylan)
Building 4
Trident Place
Mosquito Way
Hatfield
Hertfordshire AL10 9UL / GB
Opponent's representative
O'Connell, Maura, et al, et al
FRKelly
27 Clyde Road
Dublin D04 F838 / IE
 [N/P]
Former [2015/38]
Opponent(s)01  12.08.2015    ADMISSIBLE
Generics [UK] Limited (trading as Mylan)
Building 4
Trident Place
Mosquito Way
Hatfield
Hertfordshire AL10 9UL / GB
Opponent's representative
O'Connell, Maura, et al, et al
FRKelly
27 Clyde Road
Ballsbridge
Dublin 4 / IE
18.09.2015Invitation to proprietor to file observations on the notice of opposition
16.12.2015Reply of patent proprietor to notice(s) of opposition
14.10.2016Legal effect of rejection of opposition [2017/11]
14.10.2016Date of oral proceedings
31.10.2016Despatch of minutes of oral proceedings
31.10.2016Date of despatch of rejection of opposition
Fees paidRenewal fee
26.11.2012Renewal fee patent year 03
27.11.2013Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU23.11.2010
AL12.11.2014
CY12.11.2014
EE12.11.2014
HR12.11.2014
LT12.11.2014
LV12.11.2014
MC12.11.2014
MK12.11.2014
MT12.11.2014
RO12.11.2014
RS12.11.2014
SI12.11.2014
SK12.11.2014
SM12.11.2014
LU23.11.2014
IS12.03.2015
[2018/46]
Former [2018/30]HU23.11.2010
CY12.11.2014
EE12.11.2014
HR12.11.2014
LT12.11.2014
LV12.11.2014
MC12.11.2014
MK12.11.2014
MT12.11.2014
RO12.11.2014
RS12.11.2014
SI12.11.2014
SK12.11.2014
SM12.11.2014
LU23.11.2014
IS12.03.2015
Former [2016/33]HU23.11.2010
CY12.11.2014
EE12.11.2014
HR12.11.2014
LT12.11.2014
LV12.11.2014
MC12.11.2014
MT12.11.2014
RO12.11.2014
RS12.11.2014
SI12.11.2014
SK12.11.2014
SM12.11.2014
LU23.11.2014
IS12.03.2015
Former [2016/32]HU23.11.2010
CY12.11.2014
EE12.11.2014
HR12.11.2014
LT12.11.2014
LV12.11.2014
MC12.11.2014
RO12.11.2014
RS12.11.2014
SI12.11.2014
SK12.11.2014
SM12.11.2014
IS12.03.2015
Former [2016/22]CY12.11.2014
EE12.11.2014
HR12.11.2014
LT12.11.2014
LV12.11.2014
MC12.11.2014
RO12.11.2014
RS12.11.2014
SI12.11.2014
SK12.11.2014
SM12.11.2014
IS12.03.2015
Former [2016/12]CY12.11.2014
EE12.11.2014
HR12.11.2014
LT12.11.2014
LV12.11.2014
MC12.11.2014
RO12.11.2014
RS12.11.2014
SI12.11.2014
SK12.11.2014
IS12.03.2015
Former [2015/39]CY12.11.2014
EE12.11.2014
HR12.11.2014
LT12.11.2014
LV12.11.2014
MC12.11.2014
RO12.11.2014
RS12.11.2014
SK12.11.2014
IS12.03.2015
Former [2015/37]CY12.11.2014
EE12.11.2014
HR12.11.2014
LT12.11.2014
LV12.11.2014
RO12.11.2014
RS12.11.2014
SK12.11.2014
IS12.03.2015
Former [2015/36]CY12.11.2014
EE12.11.2014
HR12.11.2014
LT12.11.2014
LV12.11.2014
RO12.11.2014
RS12.11.2014
BE30.11.2014
IS12.03.2015
Former [2015/35]CY12.11.2014
EE12.11.2014
HR12.11.2014
LT12.11.2014
LV12.11.2014
RS12.11.2014
BE30.11.2014
IS12.03.2015
Former [2015/30]CY12.11.2014
HR12.11.2014
LT12.11.2014
LV12.11.2014
RS12.11.2014
BE30.11.2014
IS12.03.2015
Former [2015/26]CY12.11.2014
HR12.11.2014
LT12.11.2014
LV12.11.2014
RS12.11.2014
IS12.03.2015
Former [2015/24]HR12.11.2014
LT12.11.2014
LV12.11.2014
RS12.11.2014
IS12.03.2015
Former [2015/23]LT12.11.2014
IS12.03.2015
Former [2015/20]LT12.11.2014
Documents cited:Search[A]WO2008128231  (HUTCHISON MEDIPHARMA ENTPR LTD [BS], et al) [A] 1-24* the whole document *;
 [AP]WO2010025138  (HUTCHISON MEDIPHARMA ENTPR LTD [BS], et al) [AP] 1-24 * the whole document *
International search[A]US2008255172  (SU WEI-GUO [CN], et al);
 [A]CN101289444  (HUTCHISON MEDIPHARMA SHANGHAI [CN])
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.